Pfenex Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 06/30/20 Q2

ended 03/31/20 Q1

ended 12/31/19 FY 2019

ended 09/30/19 Q3

ended 06/30/19 Q2

Prospectuses and Registrations Filter

Securities registration termination

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Blair William & Co/Il

Primecap Management

Weiss Asset Management LP

Weiss Asset Management LP

Ligand Pharmaceuticals Incorporated

News Filter

Ligand Completes Acquisition of Pfenex Inc

Tender and Support Agreement

Reports Second Quarter 2020 Results and Provides Business Update

Announces Positive European CHMP Opinion for PF708 (EU Brand Name: Livogiva™) and New Partnership in Latin America, and Provides CRM197 Business Update

Announces U.S. Commercial Launch of Teriparatide Injection

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Confidential treatment order

Correspondence with the SEC

Correspondence with the SEC